Key result
Amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells, highlighting a potential target for neurologic and psychiatric diseases.
Key points are not available for this paper at this time.
receptor, a potential target of neurologic and psychiatric diseases through this study.
No takes yet. Share an insight, caveat, or question.
Park et al. (2018) studied this question. Amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells, highlighting a potential target for neurologic and psychiatric diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: